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1. Introduction
1.1. Characteristics of the low level laser therapy (LLLT)
Laser is an acronym for ‘Light Amplification by Stimulated Emission of Radiation’. The
name of the low level laser is an abbreviation of its active medium such as GaAlAs (Gallium,
Aluminum and Arsenide) or He-Ne laser (Helium and Neon).
1.2. Designation
LLLT are designated by several parameters. The first is laser power which ranges from 10-3
to 10-1 W followed by wavelength which ranges from 300 to 10.600 nm. Pulse rate can range
from 0 (continuous) to 5000 Hz, the duration of pulse can range from 1-500 milliseconds
with an interpulse interval of 1-500 milliseconds with a total irradiation time of 10-3000 sec‐
onds and with intensity (power x irradiation time/irradiated area) ranging from 10-2 to 102
J/cm2 [1].Therapeutic lasers are within visible red to near visible red electromagnetic spec‐
trum ranging from 630 to 980 nm. The simplest way to categorize these lasers is according to
their wavelength. The depth of laser penetration varies, and oral mucosa is quite transparent
on the wavelengths (it does not absorb light well), bone and skin are quite transparent,
whereas muscles absorb the most light [1].
1.3. Exposure
The greatest problem in the use of LLLT is finding the optimal dose of exposure. The tissue
dose is expressed by energy density measured in joules per cm² (J/cm²). Produced energy is
obtained by multiplying the laser output power in milliwatts by exposition time in seconds
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(for example 50 mW x 40 seconds=2000 mJ or 2J). For example, the area which is irradiated is
2 cm² which is multiplied by 2 J and the fluence of 2/2 is obtained (surface tissue dose is 1 J/
cm²). By decreasing the irradiated area, an increase in intensity is obtained. For example, the
irradiated area is 0.5 cm², 2J are divided by 0.5 and the dose becomes 4 J/cm² since the ener‐
gy is emitted through smaller area which increases local intensity. Since the dose is most af‐
fected by the size of the laser probe, a slim probe will result in high doses of joules per cm².
However, this does not imply that energy applied on the tissue is high, although the intensi‐
ty of the light energy emitted at the end of the slim probe was high [1]. Joules per square
centimeter (J/cm², dose, fluence) denotes the irradiation intensity on the surface of the tis‐
sues, but not the dose in the depth. It is much easier to use the term ‘energy on the spot’
(only the number of joules is calculated at each spot) which is acceptable for clinical but not
for scientific purposes. The spot denotes the size of the tip of the laser probe (spot size). A
small tip of the laser probe produces a higher concentration of power per square millimeter,
while a wider tip of the laser probe dissolves the same energy over a larger area [1]. The
main absorption of wavelength occurs in the pigmented chromophores such as hemoglobin
in the blood; therefore cardiovascular tissues absorb these wavelengths quite well. Another
important factor is melanin quantity in the target tissues which absorbs large amounts of
these wavelengths. More energy is absorbed on the surface in comparison to deeper tissues
which can lead to local tissue overheating and pain [1].
1.4. Basic principles of LLLT effects
Principles of biostimulation via therapeutic lasers was introduced more than 20 years ago
when they were used in dermatology for wound healing. According to Genovese, biological
effects caused by low level lasers are due to low energy deposited into tissues where depos‐
ited energy results in primary, secondary and general therapeutic effects. This results in the
analgesic and anti-inflammatory effects as well as in improvement in healing [2]. LLLT acts
according to the Arndt-Schulz principle which states that if the stimulus is too weak, no ef‐
fect is seen. Increased stimulation and optimal dose leads to the optimal effect; while, fur‐
ther dose increase leads to a decreased effect. Additional stimulation leads to the inhibition
of stimulation [1]. It seems that LLLT act analgesically since they improve endorphin release
and therefore inhibit nociceptive signals and control pain mediators [3]. They can also act
analgesically by inhibiting pain signals which partially leads to the transient varicosities
along the neurons which decrease impulse transmission. These lasers act on cellular reduc‐
tion-oxidative potential. Cells are acidic in a lowered redox state, but after laser irradiation
they become alkaline and afterwards they can act in an optimal way. In healthy cells, irradi‐
ation with this laser does not lead to the increase in redox potential; therefore, the laser does
not affect healthy cells. It is well known that LLLT stimulate lymphocytes, activate mast
cells, and increase production of adenosine-triphosphate in the mitochondria and prolifera‐
tion of various cell types therefore acting as anti-inflammatory [3]. Furthermore, these lasers
stimulate microcirculation which results in the change of capillary hydrostatic pressure
which in turn results in edema absorption and elimination of intermediary metabolites [3].
Studies show that laser therapy leads to the increase in ascorbic acid in the fibroblasts,
which increases hydroxyproline production and consequently, collagen production. Fur‐
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thermore, these lasers lead to the increase in mitotic activity of epithelial cells and fibroblasts
[3]. On the vascular level, lasers improve proliferation of the epithelial cells, which results in
the increased number of blood vessels as well as increased production of granulation tissue.
LLLT lead to the relaxation of the smooth muscles which decreases pain [3]. Gallium-Alumi‐
num-Arsenide laser (BTL-5000, www.btl.hr) was used at the Department of Oral Medicine,
School of Dental Medicine, University of Zagreb. Results of some studies have already been
reported while some studies are still in progress. The results of our studies have shown that
this type of laser is quite useful in patients with hyposalivation. Also, it has been shown to
be successful in treatment of patients with recurrent herpes infection since the lesions heal
more rapidly. The best results are seen in patients who had lower alveolar nerve damage
usually after the third molar surgery. The patients were suffering from paresthesia and neu‐
ropathic pain which subsided in a significant number of patients after therapy. It has also
been noticed that 20 laser therapy sessions are needed instead of the usual ten. Chronic
states (pain, paresthesia and wounds) are treated once or twice a week since there is a cumu‐
lative laser effect. Patients suffering from pain might experience even stronger pain after la‐
ser therapy. This condition is temporary and reflects actual improvement of the patient’s
condition. The pain level decreases within 24 hours. It is of utmost importance to inform the
patient about this transient side effect before initiating therapy.
1.5. General contraindications for LLLT
Therapeutic lasers weaker than 500 mW are considered to be devices of low risk according
to the USA Food and Drug Administration. Naturally, the use of protective glasses both for
the patient and the clinician is a must. In patients with coagulation disorders the use of
LLLT should be avoided since they interfere with blood circulation in a way still unknown.
Presences of malignant disease as well as precancerous lesions are also contraindications
since LLLT stimulates cell growth. Irradiation of all endocrine glands, especially the thyroid
gland should be avoided. During pregnancy, menstrual cycle, febrile conditions, in epileptic
patients and those who have cochlear implants the use of lasers is not indicated [1,2].
1.6. Laser hygiene
If the laser probe is inseparable from the device, it can be disinfected with disinfectants for
surfaces and then it can be covered with sterile transparent materials or other disposable
barrier protections. If the probe can be separated from the device, it can be sterilized [1].
2. Applications of LLLT
2.1. Recurrent aphthous ulcers (RAU)
Tezel et al. [4] investigated the use of NdYAG laser on 20 patients with recurrent aphthous
ulcerations. The patients reported significantly less pain as well as functional complications
after laser therapy. Also, they stated that they experienced faster healing compared to the
usual medication therapy.
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Zand et al. [5] have investigated the use of CO2 laser (1W of defocused continuous mode) in
15 patients with recurrent aphthous ulcerations in comparison to the placebo (recurrent aph‐
thous ulcerations which were not treated). Both ulcerations were covered with transparent
gel without the use of anesthetics. The power of CO2 laser was 2-5mW after passing through
gel which did not significantly increase the temperature. The results of the same study [5]
show that one treatment with use of CO2 laser of low intensity instantly reduces pain in pa‐
tients with recurrent aphthous ulcerations without any adverse effects.
2.2. Oral lichen planus (OLP)
Jajarm et al. [6] investigated the use of 630 nm laser in 15 patients with erosive-atrophic li‐
chen planus twice a week. The same authors (6) concluded that the laser was equally effec‐
tive in the treatment of oral lichen planus as was topically applied corticosteroids and
without any side effects.
Cafaro et al. [7] treated 13 patients with OLP using the pulsed diode laser (GaAs). The pa‐
tients were exposed to the pulsed infrared laser (4J/cm² for one minute); the irradiated area
was 0.8 cm. The same authors [7] concluded that there was a significant decrease in the le‐
sions and decreased pain without any side effects.
Trehan and Taylor [8] used a 308 nm laser on nine patients with OLP with the first dose of
100 mJ/cm² once a week. The same authors [8] reported that treatments were pain-free and
well tolerated. Five patients experienced improvement after seven therapy sessions with this
laser and the authors concluded that the therapy was successful. In our opinion, the use of
LLLT should be avoided in patients with oral lichen planus because OLP is a precancerous
lesion and therefore additional stimulation of cell growth may be dangerous.
2.3. Herpes simplex infections
Schindl and Neumann [9] evaluated the effect of low level laser therapy (wavelength 690
nm, intensity 80 mW/cm², dose 48J/cm²) in 50 patients with recurrent perioral herpes (at
least once a month during six months). Patients were given therapy every day for two
weeks; the control group was given placebo therapy with laser as well. The average interval
without herpes lesions was 37.5 weeks in patients who received laser therapy and 3 weeks
in patients who received placebo and the difference was significant. The same authors [9]
concluded that ten treatments with laser significantly decreased incidence of local recurrent
herpes infection. De Carvalho et al. [10] used a laser of 780 nm wavelength, 60mW; 3 J/cm²
or 4.5J/cm² once a week during ten weeks. In patients treated with laser (in comparison to
the patients who were given medications), a significant decrease in herpes lesions and in‐
flammatory edema was seen; however there was no significant decrease in pain or monthly
recurrences.
Munoz Sanchez et al. [11] used a 670 nm wavelength laser, power output of 40 mW; 1.6J;
2.04J7cm², 51 mW/cm² applied to the each vesicle in the prodromal stage and 4.8J on the
crust together with 1.2J on the cervical vertebra C2-C3. The same authors [11] concluded
A Textbook of Advanced Oral and Maxillofacial Surgery330
that laser therapy improves healing in the beginning and prolongs the intervals between re‐
currences, that is, those patients have fewer recurrences.
Marrotti et al. [12] used a 660 nm wavelength laser, energy density of 120 J/cm², output pow‐
er of 40 mW, during two minutes on spot and 4.8J of energy per spot on four spots. After 24
hours, the patients returned and then 3.8J/cm² and 15mW were applied to their lesions (the
total dose was 0.6J). The same procedure was repeated after 72 hours and one week after.
There were no significant side effects and herpetic lesions healed faster. Carvalho-Ferreira et
al. [13] described two patients with herpetic infection who were treated five times with laser
(660 nm wavelength, 30J/cm² of continuous mode and power density of 100mW which was
applied for 8 seconds). Remission occurred after five days without reoccurrences during the
next 17 months in both patients.
2.4. Xerostomia
Vidović-Juras et al. [14] treated 17 patients with xerostomia and reported a significant in‐
crease in salivary flow rate. The same authors (14) used the BTL-5000 laser with use of infra‐
red laser with a density of 1.8 J/cm², frequency 5.2Hz, output power 30 mV during ten
treatments. Salivary flow rate was initially 0.6±0.3 ml/5 min which increased to 1.1±0.8 ml/5
min. Lončar et al. [15] concluded that pulsed GaAlAs laser, wavelength 904 nm applied to
the both parotid and submandibular glands was efficient in reducing xerostomia. The dis‐
tance of laser probe was 0.5 cm whereas the irradiation was 246 mW/cm². Exposition time
was 120 seconds a day during ten days. Average density of energy was 29.5 J/cm². Salivary
flow rate increased to 0.13 mL/min from initial 0.05 mL/min and the result was significant.
Simoes et al. [16] treated a 60-year-old person suffering from Sjogren’s syndrome by use of
laser with a wavelength of 780 nm and average density of energy 3.8 J/cm² and output pow‐
er of 15 mW at the area of parotid, submandibular and sublingual glands, three times a
week for 8 months. The same authors [16] concluded that this therapy was effective for xero‐
stomia. Simoes et al. [17] also reported that diode laser was beneficial in patients after thera‐
peutic head and neck irradiation (660 nm, 6J/cm2, 0.24 J, 40 mW). One group of 12 patients
was given laser therapy three times a week, while the other group received laser therapy
once a week. The same authors concluded that laser therapy is beneficial to patients with
xerostomia.
2.5. Burning mouth syndrome (BMS)
Yang and Huang [18] treated 17 patients with burning mouth syndrome by use of laser with
the wavelength of 880 nm, output power 3W, 50 msec of intermittent pulse and frequency of
10 Hz which was equivalent to 1.5 W/cm² (3Wx0.05 msecx10 Hz=1,5W/cm²). Depending on
the involved area, laser was applied to the area 1cm² for 70 seconds. All the patients re‐
ceived therapy between one and seven times. The average pain score before treatment was
6.7 and the results showed average pain decrease of 47.6%. Kato et al. [19] treated 11 pa‐
tients with BMS once a week during three weeks with wavelengths of 790 nm. Exposition
time was calculated on the energy density of 6J/cm², output power of 120 mW. Burning
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symptoms were significantly decreased (80% less) when compared to symptoms before
treatment.
Dos Santos et al. [20] reported that 10 BMS patients were treated once a week during ten
weeks by use of continuous wavelength of 660 nm, power 40 mW, 20 J/cm², 0.8 J/spot. All
the patients reported improvement which was seen on visual analogue scale up to 58% after
the tenth session. Vukoja et al. [21] applied the diode laser (800 nm, 3W, 50 msec, 50 Hz
which is equivalent to average power of 1.5 W/cm2) to patients with BMS which was benefi‐
cial even when the laser was switched off which correlates with a placebo effect.
2.6. Mucositis
Cowen et al. [22] treated 30 patients who were exposed to chemotherapy and radiotherapy
after transplantation of peripheral cells or bone marrow with LLLT in order to eliminate
symptoms of mucositis. He-Ne laser (632.8 nm, 60 mW) was applied daily on five spots
within the oral cavity. Cumulative findings of oral mucositis as well as daily mucositis index
were significantly decreased in patients who were treated with laser. Furthermore, patients
treated with laser had decreased pain scores and decreased xerostomia symptoms whereas
their swallowing abilities were increased compared to the ones who did not receive laser
therapy.
Campos et al. [23] directed continuous laser diode (660nm, 40 mW, 6 J/cm2) to the entire oral
cavity while laser diode of greater power (1W, 10 seconds applied to 1 cm of mucositis, i.e
10 J/cm²) was used defocused only on ulcerative lesions. After the first application of laser
therapy, patients reported decreased pain and xerostomia levels and significant improve‐
ment occurred after five laser therapy sessions. In the end, seventeen laser irradiations were
needed in order to eliminate all lesions of oral mucositis. De Castro et al. [24] treated 75 pa‐
tients by use of He-Ne laser after they had finished chemotherapy and radiotherapy due to
head and neck carcinomas. They used laser of 2.5 J/cm² or placebo laser. The number of pa‐
tients who had stage 3 and 4 mucositis and who were treated with laser was significantly
lower compared to the ones treated with placebo laser. De Lima et al. [25] found out that
low level laser therapy (GaAlAs; 2.5 J/cm2, 600 nm, 10mW) was not efficient in reducing
stage 3 or 4 of mucositis, although marginal benefits could not be excluded in terms of re‐
ducing unplanned pauses in radiotherapy.
2.7. Paresthesia
During the surgical procedures in oral surgery, various nerve disturbances may develop
that usually affect the inferior alveolar nerve. During sagittal osteotomy in order to extract
third molars, in 5.5% to 100% of cases the lower alveolar nerve may be damaged.
Miloro and Repasky [26] found that LLLT has significant influence on neurosensory recov‐
ery after sagittal osteotomy in the region of the mandibular ramus. The same authors ap‐
plied a dose of 4-6 J during seven treatments. This was also confirmed by Khullar et al. [27]
as well as by other authors. Khullar et al. [27] treated 13 patients with damaged lower alveo‐
lar nerves with the GaAlAs laser of 820 nm wavelength (4-6 J applied in every treatment
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along the distribution of the nerve in 20 treatments). The same authors reported significant
improvement in mechanoreceptive perception of the inferior alveolar nerve; however, there
were no significant differences in thermal sensitivity of the nerve between the study and
control groups. Ozen et al. [28] successfully treated four patients who had paresthesia one
year after surgical procedures on the third molars. They used the GaAlAs diode laser of
wavelength 820-830 nm, 6 J during every treatment for 90 seconds in 20 laser applications. In
all patients, neurosensory improvement was seen which was shown in objective tests (visual
analogue scale, two point discrimination test).
2.8. Implants
The efficacy of laser is highest immediately after implant placement and during the next two
weeks. After implant placement in order to reduce postoperative pain and edema, one dose
of infrared laser may be applied. If the patient is eager to attend laser therapy a few times,
osseointegration will be enhanced [29].
2.9. Pain from orthodontic treatment
LLLT may be used during orthodontic treatment in order to reduce pain and also for the
stimulation of tooth movement since it has been reported that a dose of 5.25 J/cm² leads to
the increased orthodontic mobility. Higher doses of 35J/cm² lead to the decreased orthodon‐
tic mobility [30]. Soussa et al. [31] retracted 13 teeth by use of force of 150 g on each side
using coil spring for three days and after diode laser once a month. They reported signifi‐
cant increase in tooth movement in comparison with teeth which were not treated with la‐
ser. Also, there were no significant differences in bone resorption or canine roots whether
the laser was used or not. Therefore, the same authors suggested that the use of lasers to‐
gether with orthodontic treatment might shorten orthodontic treatment. Altan et al. [32] also
reported that LLLT (diode laser, 780 nm, 20 mW, 10 sec., 5J/cm2) enhances the process of
bone remodeling by stimulating osteoblastic and osteoclastic cell proliferation. On the other
hand, Marquezan et al. [33] could not confirm the efficacy of the GaAlAs laser of 830 nm
and power output of 100 mW on orthodontic tooth movement in rats. However, the number
of osteoclasts increased when the laser was used every day. Xiaoting et al. [34] reported that
LLLT was efficient in patients who received orthodontic appliances. However, analgesics
were more efficient regardless of the type used (ibuprofen, acetaminophen, and aspirin).
Tortamano et al. [35] concluded that lasers (GaAlAs, 830 nm, output power 30 mW) were
efficient during the arch insertion, because patients reported lower pain scores and pain in‐
tensity during the most painful day. Also, their pain subsided earlier in comparison to the
ones who were not treated by laser. The patients were given a dose of 2.5 J/cm² on both sides
of the tooth (buccal and lingual). Turhani et al. [36] used mini laser of 670 nm wavelenght
and output power of 75 mW during 30 seconds on each tooth. After bracket placement, the
perception of pain was decreased after six and 30 hours. The same authors (36) concluded
that LLLT may have positive effects on patients not only immediately after bracket place‐
ment but also during orthodontic treatment.




Obradović et al. [37] treated patients with diabetes mellitus and periodontal disease by use
of LLLT (670 nm, 5 mW, 2 J/cm², 16 minutes for five days) together with conventional perio‐
dontal treatment and concluded that healing was improved as well as collagenization and
homogenization in gingival lamina propria on the basis of histopathological findings. Igić et
al. [38] treated 140 adolescents with chronic gingivitis by use of laser and conventional ther‐
apy and concluded that there was a significant difference in plaque and bleeding indices be‐
fore and after therapy. The result was more pronounced in the group which was treated
with laser. Theodoro et al. [39] used photodynamic therapy by use of LLLT in patients with
chronic periodontal disease. The control group consisted of patients with periodontal dis‐
ease who were subjected only to conventional periodontal therapy. After 180 days, there
was a significant difference based on the finding of periodontal pathogens in patients treat‐
ed with conventional periodontal therapy as well as with laser. However, there were no sig‐
nificant differences in the clinical outcome of both therapies. Aykol et al. [40] used the
GaAlAs diode laser of 808 nm wavelength, power output 4J/cm² on the gingiva of the first,
second and seventh day. On each evaluation, every day patients who were subjected to laser
therapy had better scores in bleeding sulcus indices, depth of clinical attachment and prob‐
ing depth in comparison to the control group. The same authors concluded that LLLT is a
potent additional therapy to non-surgical periodontal treatments since it hastens periodon‐
tal healing. Lui et al. [41] found out that there were no differences in periodontal parameters
after 3 months of therapy between persons who had laser therapy and those who had not.
There was a significant difference after a week and month in those treated with laser; there‐
fore the same authors concluded that laser therapy is effective only for a short period of
time. However, Pejčić et al. [42] concluded that laser therapy was beneficial to patients with
periodontal disease since there was a significant difference after six months in plaque index,
gingival index and bleeding on probing. Rotundo et al. [43] reported that there were no dif‐
ferences in clinical attachment gain after 6 months of ErYAG laser therapy in comparison to
the control group which was subjected only to supragingival scaling.
2.11. Dentin hypersensitivity
There are a few theories claiming that the use of LLLT decreases dentin hypersensitivity by
decreasing the adhesion of dentin tubuli, by dissolution or dentin recrystallization, evapora‐
tion of dentin fluid, or analgesic effect which is connected with depressed nerve transmis‐
sion or by obliteration of dentin tubuli with tertiary dentin [44]. Irradiation with the GaAlAs
laser with maximal dose of 60 mW does not affect enamel or dentin surface morphological‐
ly. However, a small amount of laser energy of 830 nm wavelength passes through hard tis‐
sues in the pulp and therefore immediate analgesic effect is seen as a consequence of
depressed transmission through nerves, probably by blocking afferent C fibers [44]. Yilmaz
et al. [44] reported that one dose of irradiation with Cr YSGG (30 seconds, 0.25 W, 20 Hz, =%
water and 10% air) or with GaAlAs laser (60 seconds, 8.5 J/cm²) was efficient in decreasing
dentin hypersensitivity, which was confirmed in other studies (Kimura et al. [45], Corona et
al. [46] as well as Sicilie et al. [47]. Sgolastra et al. [48] concluded that treatment of dentin
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hypersensitivity by use of LLLT should be considered experimental since there are only
three studies which might be considered as controlled randomized trials and all of them
have serious drawbacks which lead to the conclusion that LLLT might be pure placebo ef‐
fect in patients with dentin hypersensitivity. It seems that this treatment of dentin hypersen‐
sitivity would be too simple since dentists use multi-interventional measures to control
dentin hypersensitivity (reduction of corrosive food and drinks, change in the brushing
techniques, disuse of chewing gums, change of toothpaste, etc). Tanboga et al. [49] evaluated
the efficacy of LLLT (Er:YAG) on pain before cavity preparation in children. They found out
that the use of LLLT significantly decreased pain in comparison to the children who did not
receive laser therapy before cavity preparation.
2.12. Temporomandibular disorders
Oz et al. [50] applied LLLT in twenty persons who suffered from myofascial pain dysfunc‐
tion syndrome during ten treatments (820 nm, 3 J/cm², 300 mW) and concluded that LLLT
was as efficient as the use of occlusal splint in pain management and improvement of man‐
dibular movement in patients with myofascial pain. Marini et al. [51] reported that mandib‐
ular function was improved in patients treated by laser (superpulsed GaAs, 900 nm); ten
treatments measured by use of visual analogue scale. Also, active and passive mouth open‐
ing as well as right and left lateral movements were improved after LLLT in comparison to
the given parameters in patients treated by use of non-steroid anti-inflammatory medica‐
tions. Fikackova et al. [52] treated patients with myofascial pain as well as patients with ar‐
thralgias of temporomandibular joint by use of LLLT. They used the GaAlAs laser of 10
J/cm² and 15 J/cm² and concluded that this is an effective therapy for patients with temporo‐
mandibular joint pain.
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